237 related articles for article (PubMed ID: 23255884)
1. Targeted therapies in small cell lung cancer.
Lu HY; Wang XJ; Mao WM
Oncol Lett; 2013 Jan; 5(1):3-11. PubMed ID: 23255884
[TBL] [Abstract][Full Text] [Related]
2. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
3. Treatment of small cell lung cancer in the elderly.
Rossi A; Maione P; Colantuoni G; Guerriero C; Ferrara C; Del Gaizo F; Nicolella D; Gridelli C
Oncologist; 2005; 10(6):399-411. PubMed ID: 15967834
[TBL] [Abstract][Full Text] [Related]
4. The role of new targeted therapies in small-cell lung cancer.
Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
[TBL] [Abstract][Full Text] [Related]
5. The development of targeted therapy in small cell lung cancer.
Zhang Y; He J
J Thorac Dis; 2013 Aug; 5(4):538-48. PubMed ID: 23991314
[TBL] [Abstract][Full Text] [Related]
6. Targeted drugs in small-cell lung cancer.
Santarpia M; Daffinà MG; Karachaliou N; González-Cao M; Lazzari C; Altavilla G; Rosell R
Transl Lung Cancer Res; 2016 Feb; 5(1):51-70. PubMed ID: 26958493
[TBL] [Abstract][Full Text] [Related]
7. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
[TBL] [Abstract][Full Text] [Related]
9. Transformation of NSCLC to SCLC harboring EML4-ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
Lingling X; Maoxi C; Wei Y; Jieting Z; Yuanyuan Y; Ning X
Lung Cancer; 2023 Dec; 186():107415. PubMed ID: 37907052
[TBL] [Abstract][Full Text] [Related]
10. Drugs in development for small cell lung cancer.
Serzan MT; Farid S; Liu SV
J Thorac Dis; 2020 Oct; 12(10):6298-6307. PubMed ID: 33209468
[TBL] [Abstract][Full Text] [Related]
11. Overview of chemotherapy for small cell lung cancer.
Bunn PA; Carney DN
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-69-S7-74. PubMed ID: 9194484
[TBL] [Abstract][Full Text] [Related]
12. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
13. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
15. Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.
Aboubakar Nana F; Vanderputten M; Ocak S
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31671774
[TBL] [Abstract][Full Text] [Related]
16. A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival.
Zhang CY; Sun H; Su JW; Chen YQ; Zhang SL; Zheng MY; Li YF; Huang J; Zhang C; Tai ZX; Cai M; Zhang XC; Su J; Xu CR; Yan HH; Chen HJ; Wu YL; Yang JJ
Lung Cancer; 2023 Jan; 175():68-78. PubMed ID: 36473332
[TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
Govindan R; Page N; Morgensztern D; Read W; Tierney R; Vlahiotis A; Spitznagel EL; Piccirillo J
J Clin Oncol; 2006 Oct; 24(28):4539-44. PubMed ID: 17008692
[TBL] [Abstract][Full Text] [Related]
18. Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancer.
Liu X; Xing H; Liu B
Am J Cancer Res; 2022; 12(6):2447-2464. PubMed ID: 35812062
[TBL] [Abstract][Full Text] [Related]
19. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
Gadgeel SM
Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
